Beyond Biotech podcast 15: Cullinan Oncology, Pleco Therapeutics, TikoMed
This week’s podcast has three guests. In honor of World Cancer Research Day on September…
September 23, 2022 - 4 minutes
Jim Cornall
Research identifies new treatment target for CNS injury and neurological disease
Researchers in Birmingham in the U.K. have identified a potential target for drugs to treat…
September 22, 2022 - 3 minutes
Rivus Pharmaceuticals raises $132M for treatment of obesity and cardio-metabolic disorders
Rivus Pharmaceuticals Inc. has completed a $132 million series B financing round. It was led…
September 22, 2022 - 3 minutes
Emyria starts program with neuroscience drug discovery CRO
Emyria Limited, a clinical stage biotech, is set to work with PsychoGenics, a specialist neuroscience…
September 22, 2022 - 2 minutes
National Hemophilia Foundation launches research fund
The National Hemophilia Foundation (NHF) in the U.S. has announced the launch of Pathway to…
September 22, 2022 - 4 minutes
Swiss scientists reduce resistance of dormant melanoma cells
Small-molecule targeted therapies revolutionized the treatment of metastatic melanoma, provided that the tumors carry the…
September 22, 2022 - 4 minutes
Promising MND drug slows disease progression
Scientists in the U.K. believe a new genetically-targeted therapy to treat motor neurone disease (MND)…
September 22, 2022 - 4 minutes
New study shows how prostate cancer may start
Researchers at the University of East Anglia in the U.K. say they have made an…
September 22, 2022 - 4 minutes
NodThera reveals positive results for inflammasome inhibitors
Biotech company NodThera has announced positive phase 1 clinical readouts for its first and second…
September 21, 2022 - 2 minutes
FDA clears Cellenkos ALS drug for trial
Cellenkos, Inc., a clinical stage biotech company, has announced that the U.S. Food and Drug…
September 21, 2022 - 3 minutes
Poolbeg to investigate melioidosis vaccine candidate
Poolbeg Pharma has signed an exclusive agreement with University College Dublin (UCD) through NovaUCD, the…
September 21, 2022 - 2 minutes
Hoag’s high hopes for new drug with Alzheimer’s disease trial
Hoag's Pickup Family Neurosciences Institute is initiating a clinical trial for what it says is…
September 21, 2022 - 2 minutes
